These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27471566)

  • 1. Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment.
    Polireddy K; Chen Q
    J Cancer; 2016; 7(11):1497-514. PubMed ID: 27471566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concise review on the current understanding of pancreatic cancer stem cells.
    Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
    J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer.
    Wang J; Nikhil K; Viccaro K; Chang L; White J; Shah K
    BMC Biol; 2017 Feb; 15(1):10. PubMed ID: 28193222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer stem cells: new insight into a stubborn disease.
    Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
    Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells.
    Rodriguez-Aznar E; Wiesmüller L; Sainz B; Hermann PC
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31398893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.
    Ishiwata T
    Pathol Int; 2016 Nov; 66(11):601-608. PubMed ID: 27510923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells.
    Wang F; Ma L; Zhang Z; Liu X; Gao H; Zhuang Y; Yang P; Kornmann M; Tian X; Yang Y
    J Cancer; 2016; 7(4):408-17. PubMed ID: 26918054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Notch signalling pathway of cancer stem cells.
    Venkatesh V; Nataraj R; Thangaraj GS; Karthikeyan M; Gnanasekaran A; Kaginelli SB; Kuppanna G; Kallappa CG; Basalingappa KM
    Stem Cell Investig; 2018; 5():5. PubMed ID: 29682512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer.
    Basu M; Philipp LM; Baines JF; Sebens S
    Front Oncol; 2021; 11():740606. PubMed ID: 34631577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into pancreatic cancer stem cells.
    Rao CV; Mohammed A
    World J Stem Cells; 2015 Apr; 7(3):547-55. PubMed ID: 25914762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies.
    Tanabe S; Quader S; Cabral H; Ono R
    Front Pharmacol; 2020; 11():904. PubMed ID: 32625096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers.
    Luo Z; Li Y; Zuo M; Liu C; Tian W; Yan D; Wang H; Li D
    Mol Carcinog; 2017 May; 56(5):1438-1448. PubMed ID: 27996162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
    Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
    Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.